Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
boston blog main
boston top stories
clinical trials
fda
3
×
life sciences
national blog main
ipo
renaissance capital
san diego blog main
san diego top stories
480 biomedical
antibiotics
arsenal medical
arvinas
astrazeneca
biotech ipos
bob langer
boulder/denver
boulder/denver blog main
boulder/denver top stories
carbapenem-resistant enterobacteriaceae
celgene
chronic rhinosinusitis
covid-19
deals
detroit
detroit blog main
detroit top stories
drug delivery
drugs
dyne therapeutics
entasis therapeutics
genzyme
george whitesides
gritstone oncology
guardant health
indiana
indiana blog main
What
company
3
×
ipo
3
×
developing
million
raised
therapeutics
way
biotech
biotechs
brings
chose
close
debut
device
disorders
drug
dyne
dyne’s
firms
genetic
ipos
late
life
lyra
make
markets
medical
medicines
muscle
muscular
new
nose
noses
open
persistently
preclinical
public
q
quarter
raises
Language
unset
Current search:
fda
×
company
×
ipo
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way